Phenominer Database Results (138 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Average Type Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
F344/DuCrlCrlj plasma glucose level fasting (for 12 hours) then glucose solution, 2.8M (2 g/kg) Ogino Genom 2000 Nov 15;70(1):19-25. blood glucose amount male 245.0 days 15 80.0 mg/dl 1.24 4.8 oral glucose tolerance test tail vein 0 gastric gavage min converted from mg/dl 11404 83
F344/DuCrlCrlj abdominal fat pad weight control condition Ogino Genom 2000 Nov 15;70(1):19-25. abdominal fat pad mass male 252.0 days 15 33.4 g 0.85 3.3 post excision weight measurement 11412 83
F344/DuCrlCrlj mesenteric fat pad weight control condition Ogino Genom 2000 Nov 15;70(1):19-25. mesenteric fat pad mass male 252.0 days 15 11.5 g 0.34 1.3 post excision weight measurement 0.0 11413 83
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 65.0 days 15 169.2 mg/dl 5.4 20.91 intraperitoneal glucose tolerance test tail vein post glucose injection 30 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11458 85
F344/DuCrlCrlj body weight control condition (for 185 days) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. body mass male 185.0 days 9 365.0 g 9.0 27.0 body weighing method 0.0 11486 85
F344/DuCrlCrlj plasma glucose level fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58 blood glucose amount male 210.0 days 7 104.0 mg/dl 6.1 16.14 oral glucose tolerance test tail glucose challenge by gastric gavage min Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan) 13201 228
F344/DuCrlCrlj plasma glucose level fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58 blood glucose amount male 210.0 days 7 124.1 mg/dl 1.6 4.23 oral glucose tolerance test tail glucose challenge by gastric gavage 30 min Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan) 13202 228
F344/DuCrlCrlj retroperitoneal fat pad weight control condition Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6. retroperitoneal fat pad mass male 245.0 days 12 11.7 g 0.2 0.7 post excision weight measurement 12434 262
F344/DuCrlCrlj abdominal fat pad weight control condition Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6. abdominal fat pad mass male 245.0 days 12 34.4 g 0.66 2.3 post excision weight measurement 12436 262
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95.0 days 15 0.07 mg/dl 0.01 0.04 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 30 min 67637 85
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95.0 days 20 90.0 mg/dl intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection min 67647 85
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95.0 days 20 118.8 mg/dl intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 60 min 67650 85
F344/DuCrlCrlj both kidneys wet weight as percentage of body weight specific pathogen-free condition NBRP Organ Weight data kidney mass male 70.0 days 6 0.61 % 0.01 0.02 Shimadzu electronic balance post excision weight measurement 71578 41
F344/DuCrlCrlj mean corpuscular hemoglobin concentration fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood hemoglobin amount male 70.0 days 6 31.2 g/dl 0.41 1.0 automated cell/particle size/count analysis method Sysmex, F-800 type 76882 1498
F344/DuCrlCrlj plasma total protein level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood total protein amount male 70.0 days 6 59.0 mg/ml 0.82 2.0 automated plasma total protein analysis Hitachi, model 7170 76890 1498
F344/DuCrlCrlj plasma total cholesterol level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood cholesterol amount male 70.0 days 6 49.0 mg/dl 1.63 4.0 automated plasma analysis PMID:15591307 76894 1498
F344/DuCrlCrlj plasma urea nitrogen level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood urea nitrogen amount male 70.0 days 6 7.07 mmol/l 0.15 0.36 automated plasma analysis PMID:15591307 76899 1498
F344/DuCrlCrlj total plasma calcium level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood calcium amount male 70.0 days 6 10.3 mg/dl 0.04 0.1 automated blood electrolyte analysis Hitachi, model 7170 76902 1498
F344/DuCrlCrlj plasma sodium level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood sodium amount male 70.0 days 6 148.8 mmol/l 0.45 1.1 automated blood electrolyte analysis Analytical intruments, PVA alpha II 76903 1498
F344/DuCrlCrlj blood lymphocyte count to total leukocyte count ratio fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data lymphocyte quantity male 70.0 days 6 81.0 % 2.45 6.0 automated differential white blood cell count test May-Giemsa staining 76910 1498
F344/DuCrlCrlj blood monocyte count to total leukocyte count ratio fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data monocyte quantity male 70.0 days 6 5.0 % 1.22 3.0 automated differential white blood cell count test May-Giemsa staining 76911 1498
F344/DuCrlCrlj urine potassium excretion rate to body weight ratio 0.9% sodium chloride solution (25 ml/kg) NBRP Urine Volume and Urine Electrolyte data urine potassium amount male 63.0 days 6 143.0 uEq/100g/6 hrs 10.61 26.0 automated urine analysis Analytical intruments, PVA alpha II 94873 1662
F344/DuCrlCrlj urine chloride excretion rate to body weight ratio 0.9% sodium chloride solution (25 ml/kg) NBRP Urine Volume and Urine Electrolyte data urine chloride amount male 63.0 days 6 274.0 uEq/100g/6 hrs 22.45 55.0 automated urine analysis 94875 1662
F344/DuCrlCrlj blood glucose level area under curve (AUC) fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58 blood glucose amount male 210.0 days 7 15300.0 (mg/dl) x min 206.7 546.88 oral glucose tolerance test tail 0.0 gastric gavage Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan) 67194 228
F344/DuCrlCrlj blood glucose level partial pancreatectomy (70 %) Ogino GenetRes 73:29 '99 blood glucose amount male 49.0 days 9 123.4 mg/dl 2.2 6.6 blood glucose test strip read by electrochemical glucometer tail 0.0 post pancreatectomy 7 days Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan converted from mg/dl 11419 84
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95.0 days 15 91.8 mg/dl 1.8 6.97 intraperitoneal glucose tolerance test tail vein post glucose injection min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11428 85
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 65.0 days 15 286.2 mg/dl 7.2 27.89 intraperitoneal glucose tolerance test tail vein post glucose injection 15 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11461 85
F344/DuCrlCrlj plasma glucose level fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58 blood glucose amount male 210.0 days 7 128.0 mg/dl 2.4 6.35 oral glucose tolerance test tail glucose challenge by gastric gavage 120 min Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan) 13205 228
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 65.0 days 15 0.0 mg/dl 0.0 0.0 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection min 67623 85
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 65.0 days 15 0.07 mg/dl 0.01 0.04 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 15 min 67625 85
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95.0 days 15 0.01 mg/dl 0.0 0.01 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection min 67632 85
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95.0 days 20 248.4 mg/dl intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 30 min 67649 85
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95.0 days 20 0.0 mg/dl intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection min 67656 85
F344/DuCrlCrlj body weight specific pathogen-free condition NBRP Body Weight data body mass male 70.0 days 6 218.4 g 3.72 9.1 whole body digital scale 70683 21
F344/DuCrlCrlj post-insult time to onset of T-cell lymphoma controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40.0 days-365.0 days 29 106.6 d 2.9 15.6 fluorescence-activated cell sorting method 0.0 70037 1280
F344/DuCrlCrlj brain wet weight specific pathogen-free condition NBRP Organ Weight data brain mass male 70.0 days 6 1.86 g 0.02 0.04 Shimadzu electronic balance post excision weight measurement 71569 41
F344/DuCrlCrlj heart wet weight specific pathogen-free condition NBRP Organ Weight data heart mass male 70.0 days 6 0.72 g 0.01 0.03 Shimadzu electronic balance post excision weight measurement 71571 41
F344/DuCrlCrlj spleen wet weight specific pathogen-free condition NBRP Organ Weight data spleen mass male 70.0 days 6 0.44 g 0.01 0.03 Shimadzu electronic balance post excision weight measurement 71581 41
F344/DuCrlCrlj hematocrit fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data erythrocyte quantity male 70.0 days 6 56.2 % 0.49 1.2 automated cell/particle size/count analysis method Sysmex, F-800 type 76879 1498
F344/DuCrlCrlj mean corpuscular hemoglobin fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood hemoglobin amount male 70.0 days 6 18.0 pg 0.04 0.1 automated cell/particle size/count analysis method Sysmex, F-800 type 76881 1498
F344/DuCrlCrlj activated partial thromboplastin time fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood coagulation trait male 70.0 days 6 14.4 s 1.06 2.6 automated coagulometer method Sysmex, CA-3000 type 76886 1498
F344/DuCrlCrlj blood eosinophil count to total leukocyte count ratio fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data eosinophil quantity male 70.0 days 6 1.0 % 0.41 1.0 automated differential white blood cell count test May-Giemsa staining 76907 1498
F344/DuCrlCrlj non-specified leukocyte count to total leukocyte count ratio fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data leukocyte quantity male 70.0 days 6 0.0 % 0.0 0.0 automated differential white blood cell count test May-Giemsa staining unidentified differential wbc 76912 1498
F344/DuCrlCrlj timed urine volume 0.9% sodium chloride solution (25 ml/kg) NBRP Urine Volume and Urine Electrolyte data urine output male 63.0 days 6 16.68 ml/d 1.03 2.52 metabolic cage urine volume measurement method 94868 1662
F344/DuCrlCrlj urine sodium excretion rate to body weight ratio 0.9% sodium chloride solution (25 ml/kg) NBRP Urine Volume and Urine Electrolyte data urine sodium amount male 63.0 days 6 0.01 uEq/min/g 0.0 0.0 automated urine analysis Analytical intruments, PVA alpha II 94871 1662
F344/DuCrlCrlj systolic blood pressure specific pathogen-free condition NBRP Blood Pressure and Heart Rate data arterial blood pressure trait male 56.0 days-70.0 days 6 serial mean 140.0 mmHg 4.9 12.0 tail cuff photoplethysmography NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan 74937 14
F344/DuCrlCrlj heart rate specific pathogen-free condition NBRP Blood Pressure and Heart Rate data heart pumping trait male 56.0 days-70.0 days 6 serial mean 426.0 beats/min 14.7 36.0 tail cuff photoplethysmography NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan 74938 14
F344/DuCrlCrlj plasma glucose level fasting (for 16 hours) then glucose solution Hirashima T, et al., Diabetes Res Clin Pract 1995 Feb;27(2):91-6. blood glucose amount male 210.0 days 7 128.0 mg/dl 2.27 6.0 oral glucose tolerance test 0.0 oral dose 120 min 67279 729
F344/DuCrlCrlj blood glucose level partial pancreatectomy (70 %) Ogino GenetRes 73:29 '99 blood glucose amount male 63.0 days 9 109.9 mg/dl 1.6 4.8 blood glucose test strip read by electrochemical glucometer tail 0.0 post pancreatectomy 21 days Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan converted from mg/dl 11417 84
F344/DuCrlCrlj blood glucose level partial pancreatectomy (70 %) Ogino GenetRes 73:29 '99 blood glucose amount male 56.0 days 9 120.1 mg/dl 5.9 17.7 blood glucose test strip read by electrochemical glucometer tail 0.0 post pancreatectomy 14 days Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan converted from mg/dl 11418 84
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 65.0 days 15 86.4 mg/dl 3.6 13.94 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 90 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11451 85
F344/DuCrlCrlj body weight control condition (for 65 days) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. body mass male 65.0 days 15 207.0 g 3.0 11.62 body weighing method 0.0 11465 85
F344/DuCrlCrlj serum triglyceride level fasting (between 6 and 7 hours) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood triglyceride amount male 185.0 days 9 203.54 mg/dl 7.96 23.89 serum triglyceride analysis tail vein Vitros TRIG slides (Johnson & Johnson, Rochester, NY) 11476 85
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 185.0 days 9 102.6 mg/dl 1.8 5.4 blood glucose analysis tail vein Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11479 85
F344/DuCrlCrlj epididymal fat pad weight control condition Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. epididymal fat pad mass male 185.0 days 9 10.5 g 0.7 2.1 post excision weight measurement 11483 85
F344/DuCrlCrlj plasma glucose level fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58 blood glucose amount male 210.0 days 7 130.9 mg/dl 2.9 7.67 oral glucose tolerance test tail glucose challenge by gastric gavage 60 min Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan) 13203 228
F344/DuCrlCrlj plasma glucose level fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58 blood glucose amount male 210.0 days 7 139.0 mg/dl 2.4 6.35 oral glucose tolerance test tail glucose challenge by gastric gavage 90 min Glucose-B Test Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan) 13204 228
F344/DuCrlCrlj body weight control condition Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6. body mass male 245.0 days 12 393.6 g 5.31 18.4 body weighing method 12431 262
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95.0 days 15 0.08 mg/dl 0.01 0.05 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 15 min 67634 85
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95.0 days 20 334.8 mg/dl intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 15 min 67648 85
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95.0 days 20 0.01 mg/dl intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 15 min 67657 85
F344/DuCrlCrlj body weight specific pathogen-free condition NBRP Body Weight data body mass male 35.0 days 6 90.6 g 0.78 1.9 whole body digital scale 70684 21
F344/DuCrlCrlj plasma free fatty acids level fasting (for 16 hours) Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. blood free fatty acid amount male 112.0 days 15 0.65 mmol/l 0.03 0.11 automated blood analysis 0.0 "mEq/l" can not be converted to CMO:0000546's standard unit: "mmol/l" 68969 1035
F344/DuCrlCrlj mean corpuscular volume fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data erythrocyte size trait male 70.0 days 6 57.7 fl 0.65 1.6 automated cell/particle size/count analysis method Sysmex, F-800 type 76880 1498
F344/DuCrlCrlj platelet count fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data platelet quantity male 70.0 days 6 875.0 x 1000 /ul 20.82 51.0 automated cell/particle size/count analysis method Sysmex, F-800 type 76884 1498
F344/DuCrlCrlj plasma albumin level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood albumin amount male 70.0 days 6 0.36 g/l 0.0 0.01 automated plasma albumin analysis Hitachi, model 7170 76891 1498
F344/DuCrlCrlj plasma high density lipoprotein cholesterol level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood HDL cholesterol amount male 70.0 days 6 29.7 mg/dl 0.9 2.2 automated plasma analysis PMID:15591307 76895 1498
F344/DuCrlCrlj plasma creatinine level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood creatinine amount male 70.0 days 6 0.26 mg/dl 0.0 0.01 automated plasma creatinine analysis Hitachi, model 7170 76900 1498
F344/DuCrlCrlj plasma potassium level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood potassium amount male 70.0 days 6 4.03 mmol/l 0.04 0.09 automated blood electrolyte analysis Analytical intruments, PVA alpha II 76904 1498
F344/DuCrlCrlj blood basophil count to total leukocyte count ratio fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data basophil quantity male 70.0 days 6 0.0 % 0.41 1.0 automated differential white blood cell count test May-Giemsa staining 76906 1498
F344/DuCrlCrlj blood segmented neutrophil count to total leukocyte count ratio fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data neutrophil quantity male 70.0 days 6 12.0 % 2.04 5.0 automated differential white blood cell count test May-Giemsa staining segmented neutrophil % 76909 1498
F344/DuCrlCrlj brain weight to body weight ratio specific pathogen-free condition NBRP Organ Weight data brain mass male 70.0 days 6 0.91 % 0.01 0.03 Shimadzu electronic balance post excision weight measurement 71570 41
F344/DuCrlCrlj liver weight as percentage of body weight specific pathogen-free condition NBRP Organ Weight data liver mass male 70.0 days 6 2.82 % 0.02 0.05 Shimadzu electronic balance post excision weight measurement 71576 41
F344/DuCrlCrlj urine sodium level 0.9% sodium chloride solution (25 ml/kg) NBRP Urine Volume and Urine Electrolyte data urine sodium amount male 63.0 days 6 119.6 mmol/l 11.96 29.3 automated urine analysis Analytical intruments, PVA alpha II 94870 1662
F344/DuCrlCrlj body weight control condition Ogino Genom 2000 Nov 15;70(1):19-25. body mass male 245.0 days-252.0 days 15 404.4 g 5.16 20.0 body weighing method 11411 83
F344/DuCrlCrlj epididymal fat pad weight control condition Ogino Genom 2000 Nov 15;70(1):19-25. epididymal fat pad mass male 252.0 days 15 11.2 g 0.31 1.2 post excision weight measurement 0.0 11415 83
F344/DuCrlCrlj body weight control condition (for 95 days) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. body mass male 95.0 days 15 279.0 g 4.0 15.49 body weighing method 0.0 11444 85
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95.0 days 15 109.8 mg/dl 3.6 13.94 intraperitoneal glucose tolerance test tail vein post glucose injection 90 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11431 85
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 65.0 days 15 86.4 mg/dl 1.8 6.97 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11450 85
F344/DuCrlCrlj serum total cholesterol level fasting (between 6 and 7 hours) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood cholesterol amount male 185.0 days 9 81.85 mg/dl 1.93 5.79 serum total cholesterol measurement test tail vein Vitros CHOL slides (Johnson & Johnson, Rochester, NY) 11473 85
F344/DuCrlCrlj serum high density lipoprotein cholesterol level fasting (between 6 and 7 hours) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood HDL cholesterol amount male 185.0 days 9 37.07 mg/dl 0.77 2.32 serum high-density lipoprotein-cholesterol measurement test tail vein N-geneous HDL-c kit (Biomed-RK, Jonkoping, Sweden) 11470 85
F344/DuCrlCrlj body weight fasting (for 16 hours) Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58 body mass male 210.0 days 10 374.1 g 8.0 25.3 body weighing method 11968 228
F344/DuCrlCrlj mesenteric fat pad weight control condition Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6. mesenteric fat pad mass male 245.0 days 12 11.5 g 0.23 0.8 post excision weight measurement 12433 262
F344/DuCrlCrlj epididymal fat pad weight control condition Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6. epididymal fat pad mass male 245.0 days 12 11.2 g 0.26 0.9 post excision weight measurement 12435 262
F344/DuCrlCrlj plasma glucose level fasting (for 16 hours) Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. blood glucose amount male 112.0 days 15 126.0 mg/dl 5.4 20.91 plasma glucose analysis 0.0 68962 1035
F344/DuCrlCrlj plasma triglyceride level fasting (for 16 hours) Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. blood triglyceride amount male 112.0 days 15 0.55 mmol/l 0.03 0.13 automated blood analysis 0.0 68964 1035
F344/DuCrlCrlj abdominal fat pad weight fasting (for 16 hours) Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. abdominal fat pad mass male 112.0 days 15 8.13 g 0.17 0.66 post excision weight measurement 0.0 68973 1035
F344/DuCrlCrlj pancreas weight to body weight ratio partial pancreatectomy Moralejo DH, et al., Mamm Genome 1998 Oct;9(10):794-8. pancreas mass male 70.0 days 9 0.89 mg/g 0.03 0.09 post excision weight measurement 0.0 partial pancreatectomy 28 days 68240 911
F344/DuCrlCrlj percentage of study population developing T-cell lymphomas during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40.0 days-365.0 days 29 96.6 % fluorescence-activated cell sorting method 0.0 70014 1280
F344/DuCrlCrlj percentage of study population developing leukemia during a period of time controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61. leukocyte integrity trait not specified 40.0 days-365.0 days 29 0.0 % ex vivo light microscopy with immunohistochemistry 0.0 light microscopy with immuno 70060 1280
F344/DuCrlCrlj lung weight to body weight ratio specific pathogen-free condition NBRP Organ Weight data lung mass male 70.0 days 6 0.38 % 0.01 0.02 Shimadzu electronic balance post excision weight measurement 71574 41
F344/DuCrlCrlj liver wet weight specific pathogen-free condition NBRP Organ Weight data liver mass male 70.0 days 6 5.79 g 0.12 0.3 Shimadzu electronic balance post excision weight measurement 71575 41
F344/DuCrlCrlj both kidneys wet weight specific pathogen-free condition NBRP Organ Weight data kidney mass male 70.0 days 6 1.25 g 0.02 0.05 Shimadzu electronic balance post excision weight measurement 71577 41
F344/DuCrlCrlj both adrenal glands weight to body weight ratio specific pathogen-free condition NBRP Organ Weight data adrenal gland mass male 70.0 days 6 17.5 mg/100g 1.92 4.7 Shimadzu electronic balance post excision weight measurement 71580 41
F344/DuCrlCrlj both adrenal glands wet weight specific pathogen-free condition NBRP Organ Weight data adrenal gland mass male 70.0 days 6 36.0 mg 4.04 9.9 Shimadzu electronic balance post excision weight measurement 71579 41
F344/DuCrlCrlj spleen weight to body weight ratio specific pathogen-free condition NBRP Organ Weight data spleen mass male 70.0 days 6 0.22 % 0.01 0.02 Shimadzu electronic balance post excision weight measurement 71582 41
F344/DuCrlCrlj both testes wet weight to body weight ratio specific pathogen-free condition NBRP Organ Weight data testis mass male 70.0 days 6 1.35 % 0.03 0.08 Shimadzu electronic balance post excision weight measurement 71584 41
F344/DuCrlCrlj both testes wet weight specific pathogen-free condition NBRP Organ Weight data testis mass male 70.0 days 6 2.78 g 0.1 0.25 Shimadzu electronic balance post excision weight measurement 71583 41
F344/DuCrlCrlj prothrombin time fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood coagulation trait male 70.0 days 6 15.4 s 0.16 0.4 automated coagulometer method Sysmex, CA-3000 type 76885 1498
F344/DuCrlCrlj plasma aspartate aminotransferase activity level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood aspartate transaminase amount male 70.0 days 6 62.0 U/l 1.63 4.0 automated plasma analysis PMID:15591307 76887 1498
F344/DuCrlCrlj plasma alanine aminotransferase activity level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood alanine transaminase amount male 70.0 days 6 35.0 U/l 1.22 3.0 automated plasma analysis PMID:15591307 76888 1498
F344/DuCrlCrlj plasma glucose level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood glucose amount male 70.0 days 6 155.0 mg/dl 6.53 16.0 automated plasma analysis PMID:15591307 76893 1498
F344/DuCrlCrlj plasma total bilirubin level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood bilirubin amount male 70.0 days 6 0.0 mg/dl 0.0 0.0 automated plasma analysis PMID:15591307 total plasma bilirubin level 76898 1498
F344/DuCrlCrlj plasma chloride level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood chloride amount male 70.0 days 6 105.0 mmol/l 0.41 1.0 automated blood electrolyte analysis Analytical intruments, PVA alpha II 76905 1498
F344/DuCrlCrlj urine potassium level 0.9% sodium chloride solution (25 ml/kg) NBRP Urine Volume and Urine Electrolyte data urine potassium amount male 63.0 days 6 75.2 mmol/l 6.25 15.3 automated urine analysis Analytical intruments, PVA alpha II 94872 1662
F344/DuCrlCrlj body temperature specific pathogen-free condition NBRP Body Temperature data body temperature trait male 56.0 days-70.0 days 6 serial mean 37.8 degrees C 0.16 0.4 digital rectal thermometry 74939 22
F344/DuCrlCrlj plasma glucose level fasting (for 12 hours) then glucose solution, 2.8M (2 g/kg) Ogino Genom 2000 Nov 15;70(1):19-25. blood glucose amount male 245.0 days 15 92.6 mg/dl 1.65 6.4 oral glucose tolerance test tail vein 0 gastric gavage 30 min converted from mg/dl 11405 83
F344/DuCrlCrlj retroperitoneal fat pad weight control condition Ogino Genom 2000 Nov 15;70(1):19-25. retroperitoneal fat pad mass male 252.0 days 15 10.7 g 0.23 0.9 post excision weight measurement 0.0 11414 83
F344/DuCrlCrlj blood glucose level partial pancreatectomy (70 %) Ogino GenetRes 73:29 '99 blood glucose amount male 70.0 days 9 117.8 mg/dl 2.7 8.1 blood glucose test strip read by electrochemical glucometer tail 0.0 post pancreatectomy 28 days Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan converted from mg/dl 11416 84
F344/DuCrlCrlj blood glucose level control condition Ogino GenetRes 73:29 '99 blood glucose amount male 42.0 days 9 102.6 mg/dl 2.2 6.6 blood glucose test strip read by electrochemical glucometer tail 0.0 Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan converted from mg/dl 11426 84
F344/DuCrlCrlj blood glucose level partial pancreatectomy (70 %) Ogino GenetRes 73:29 '99 blood glucose amount male 45.0 days 9 115.8 mg/dl 3.4 10.2 blood glucose test strip read by electrochemical glucometer tail 0.0 post pancreatectomy 3 days Toecho Super, Kyoto Daiichi Kagaku, Kyoto, Japan converted from mg/dl 11427 84
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95.0 days 15 135.0 mg/dl 5.4 20.91 intraperitoneal glucose tolerance test tail vein post glucose injection 60 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11434 85
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95.0 days 15 219.6 mg/dl 5.4 20.91 intraperitoneal glucose tolerance test tail vein post glucose injection 30 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11437 85
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95.0 days 15 271.8 mg/dl 9.0 34.86 intraperitoneal glucose tolerance test tail vein post glucose injection 15 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11440 85
F344/DuCrlCrlj blood glucose level area under curve (AUC) fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95.0 days 15 15545.45 (mg/dl) x min 381.82 1478.78 intraperitoneal glucose tolerance test tail vein post glucose injection 90 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11446 85
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 65.0 days 15 88.2 mg/dl 3.6 13.94 intraperitoneal glucose tolerance test tail vein post glucose injection 60 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11454 85
F344/DuCrlCrlj blood glucose level area under curve (AUC) fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 65.0 days 15 12818.18 (mg/dl) x min 218.18 845.01 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 90 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11467 85
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 65.0 days 15 0.03 mg/dl 0.0 0.02 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 30 min 67628 85
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 185.0 days 9 0.02 mg/dl 0.0 0.01 enzyme linked immunosorbent assay tail vein 0.0 67644 85
F344/DuCrlCrlj blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95.0 days 20 111.6 mg/dl intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 90 min 67651 85
F344/DuCrlCrlj serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95.0 days 20 0.01 mg/dl intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 30 min 67658 85
F344/DuCrlCrlj red blood cell count fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data erythrocyte quantity male 70.0 days 6 9.75 x 10E6 cells/ul 0.09 0.21 automated cell/particle size/count analysis method Sysmex, F-800 type 76877 1498
F344/DuCrlCrlj blood hemoglobin level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood hemoglobin amount male 70.0 days 6 17.5 g/dl 0.16 0.4 automated cell/particle size/count analysis method Sysmex, F-800 type 76878 1498
F344/DuCrlCrlj white blood cell count fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data leukocyte quantity male 70.0 days 6 6.1 x 1000 cells/ul 0.33 0.8 automated cell/particle size/count analysis method Sysmex, F-800 type 76883 1498
F344/DuCrlCrlj plasma alkaline phosphatase activity level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood alkaline phosphatase amount male 70.0 days 6 504.0 IU/l 13.47 33.0 automated plasma analysis PMID:15591307 76889 1498
F344/DuCrlCrlj plasma albumin to plasma total protein ratio fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood albumin amount male 70.0 days 6 1.6 null 0.02 0.05 automated plasma protein analysis Hitachi, model 7170 plasma albumin to plasma total protein ratio 76892 1498
F344/DuCrlCrlj plasma low density lipoprotein cholesterol level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood LDL cholesterol amount male 70.0 days 6 3.0 mg/dl 0.41 1.0 automated plasma analysis PMID:15591307 76896 1498
F344/DuCrlCrlj plasma triglyceride level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood triglyceride amount male 70.0 days 6 0.93 mmol/l 0.05 0.12 automated plasma analysis PMID:15591307 76897 1498
F344/DuCrlCrlj plasma phosphate level fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data blood phosphate amount male 70.0 days 6 7.1 mg/dl 0.08 0.2 automated blood electrolyte analysis Hitachi, model 7170 76901 1498
F344/DuCrlCrlj blood band neutrophil count to total leukocyte count ratio fasting (for 16 hours) NBRP Hematology & Blood Biochemistry data neutrophil quantity male 70.0 days 6 1.0 % 0.41 1.0 automated differential white blood cell count test May-Giemsa staining band neutrophil % 76908 1498
F344/DuCrlCrlj timed urine volume to body weight ratio 0.9% sodium chloride solution (25 ml/kg) NBRP Urine Volume and Urine Electrolyte data urine output male 63.0 days 6 0.05 ul/min/g 0.0 0.01 metabolic cage urine volume measurement method 94869 1662
F344/DuCrlCrlj urine chloride level 0.9% sodium chloride solution (25 ml/kg) NBRP Urine Volume and Urine Electrolyte data urine chloride amount male 63.0 days 6 144.0 mEq/L 13.06 32.0 automated urine analysis 94874 1662
F344/DuCrlCrlj body weight specific pathogen-free condition NBRP Body Weight data body mass male 42.0 days 6 117.9 g 1.51 3.7 whole body digital scale 70685 21
F344/DuCrlCrlj plasma total cholesterol level fasting (for 16 hours) Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. blood cholesterol amount male 112.0 days 15 38.61 mg/dl 1.54 5.98 automated blood analysis 0.0 68967 1035
F344/DuCrlCrlj serum leptin level fasting (for 16 hours) Yamasaki Y, et al., Clin Exp Pharmacol Physiol 2000 Nov;27(11):881-6. blood leptin amount male 112.0 days 15 16.32 ng/ml 0.93 3.6 enzyme linked immunosorbent assay 0.0 68971 1035
F344/DuCrlCrlj pancreas wet weight partial pancreatectomy Moralejo DH, et al., Mamm Genome 1998 Oct;9(10):794-8. pancreas mass male 70.0 days 9 0.2 g 0.01 0.02 post excision weight measurement 0.0 partial pancreatectomy 28 days 68238 911
F344/DuCrlCrlj lung wet weight specific pathogen-free condition NBRP Organ Weight data lung mass male 70.0 days 6 0.78 g 0.02 0.04 Shimadzu electronic balance post excision weight measurement 71573 41
F344/DuCrlCrlj heart weight to body weight ratio specific pathogen-free condition NBRP Organ Weight data heart mass male 70.0 days 6 3.49 g/kg 0.04 0.09 Shimadzu electronic balance post excision weight measurement 71572 41